APPLICATION
ANDA087768
TYPE
ANDA
ORIGINAL APPROVAL
1982-08-11
LATEST ACTION
1995-12-28
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
BILIVISTDiscontinued
IPODATE SODIUM 500MG · CAPSULE · ORAL
Approval history
1995-12-28Labeling · Supplement 5AP
1982-08-11OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.